Nordea Investment Management Ab
Source: SEC Form 13F · as of Mar 2026Nordea Investment Management Ab holds 17 biotech & pharma companies tracked by BioSniper, totaling $888.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$888.0M
BioSniper AIPage context preserved
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 5,260,363 | $726.6M |
| REGNREGENERON PHARMACEUTICALS, INC. | 94,322 | $72.4M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 306,439 | $18.6M |
| LGNDLigand Pharmaceuticals Incorporated | 50,936 | $9.8M |
| EXELEXELIXIS, INC. | 201,553 | $8.6M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 113,902 | $6.3M |
| PTGXProtagonist Therapeutics, Inc | 51,821 | $5.3M |
| INCYIncyte Corp. | 56,919 | $5.3M |
| KNSAKiniksa Pharmaceuticals International, plc | 106,635 | $5.1M |
| ARVNARVINAS, INC. | 474,503 | $5.1M |
| ACADACADIA PHARMACEUTICALS INC | 228,125 | $4.9M |
| ARQTArcutis Biotherapeutics, Inc. | 192,920 | $4.4M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 13,346 | $4.3M |
| TEVATeva Pharmaceutical Industries Limited | 124,860 | $3.6M |
| INSMINSMED Inc | 22,247 | $3.6M |
| TGTXTG THERAPEUTICS, INC. | 79,048 | $2.6M |
| RVMDREVOLUTION MEDICINES, INC. | 14,945 | $1.4M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.